Department of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China.
Key Laboratory of Combined Multi-organ Transplantation, Ministry of Public Health, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China.
Front Med. 2018 Apr;12(2):123-129. doi: 10.1007/s11684-017-0563-2. Epub 2017 Dec 12.
Liver transplantation is a conventional treatment for terminal stage liver diseases. However, several complications still hinder the survival rate. Intestinal barrier destruction is widely observed among patients receiving liver transplant and suffering from ischemia-reperfusion or rejection injuries because of the relationship between the intestine and the liver, both in anatomy and function. Importantly, the resulting alteration of gut microbiota aggravates graft dysfunctions during the process. This article reviews the research progress for gut microbial alterations and liver transplantation. Especially, this work also evaluates research on the management of gut microbial alteration and the prediction of possible injuries utilizing microbial alteration during liver transplantation. In addition, we propose possible directions for research on gut microbial alteration during liver transplantation and offer a hypothesis on the utilization of microbial alteration in liver transplantation. The aim is not only to predict perioperative injuries but also to function as a method of treatment or even inhibit the rejection of liver transplantation.
肝移植是治疗终末期肝脏疾病的常规方法。然而,一些并发症仍然阻碍了患者的存活率。由于肠和肝在解剖和功能上的关系,接受肝移植的患者在经历缺血再灌注或排斥损伤时,肠道屏障会受到广泛破坏。重要的是,肠道微生物群的改变会在这个过程中加重移植物功能障碍。本文综述了肠道微生物改变与肝移植的研究进展。特别是,本研究还评估了在肝移植过程中利用肠道微生物改变来管理肠道微生物改变和预测可能损伤的研究。此外,我们提出了肝移植过程中肠道微生物改变研究的可能方向,并提出了利用微生物改变的假设。其目的不仅是预测围手术期损伤,而且是作为一种治疗方法,甚至是抑制肝移植排斥反应。